Clinical Trial Update: Assessment of the Response to Etoricoxib in Patients With Ankylosing Spondylitis and Inadequate Response to ≥2 NSAIDs [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the response to etoricoxib in ankylosing spondylitis patients with inadequate response to at least two NSAIDs has completed and results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Etoricoxib (etoricoxib)

Snippet

Sponsor: Spanish Foundation of Rheumatology | Conditions: Ankylosing Spondylitis | Phase 3 | Status: COMPLETED | Results posted: 2015-06-10